Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05611996 · ClinicalTrials.gov registry record · NA
PEERS Plus mHealth Enhanced Peer Support
A NA study, sponsored by Massachusetts General Hospital.
- Completed
- Registry status
- NA
- Development phase
- 34
- Enrollment target
NCT05611996: Completed NA study, sponsored by Massachusetts General Hospital.
NCT05611996 is a NA study that has completed, run by Massachusetts General Hospital. The registered enrollment target is 34 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05611996, a NA study, has completed, sponsored by Massachusetts General Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 34 participants
- Enrollment target
Study Summary
The goal of this intervention study is to design and learn whether peer support that is delivered through video chats and texts can decrease depression among older adults. Participants will be assigned to a peer support program where they will receive 8 video chats with a peer mentor who provide social support and supportive texts over 8 weeks.
Primary Outcome
Proportion of the participants who complete 80% of their weekly meetings with the peer coach.
Interventions
- BEHAVIORAL Peers plus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 34 participants |
| Start Date | 2022-12-15 |
| Est. Completion | 2025-01-17 |
| Phase | NA |
What the finished NCT05611996 record still lists
NCT05611996 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 34 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (98% lower).
The record links to 0 conditions, and to 1 intervention - of which Peers plus is the first listed.
NCT05611996 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05611996 about?
NCT05611996 is a clinical study titled "PEERS Plus mHealth Enhanced Peer Support". The goal of this intervention study is to design and learn whether peer support that is delivered through video chats and texts can decrease depression among older adults. Participants will be assigned to a peer support program where they will receive 8 video chats with a peer mentor who provide soc...
What is the current status of trial NCT05611996?
This trial is currently completed. It is a NA study. The enrollment target is 34 participants. The study started on 2022-12-15. Estimated completion is 2025-01-17.
What interventions are being tested in trial NCT05611996?
The interventions under investigation include: Peers plus (BEHAVIORAL).
Who is sponsoring clinical trial NCT05611996?
This trial is sponsored by Massachusetts General Hospital, which has 2,032 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05611996's enrollment target sits among peer trials
34 1570th of 2000 higher than 427 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02897063 · 34 participants · Phase 1
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
- NCT03906617 · 34 participants · Phase 4
Bupivacaine/Epinephrine +Dexamethasone vs. Liposomal Bupivacaine
- NCT03992378 · 34 participants · NA
Neuromodulation to Regulate Inflammation and Autonomic Imbalance in Sepsis
- NCT04047849 · 34 participants · Phase 4
Latency Antibiotics in Previable PPROM, 18 0/7- 22 6/7 WGA
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI